Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05996484 |
|---|---|
| Brief Title: | Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma |
| First Submitted : | August 10, 2023 |
| First Submitted that Met QC Criteria : | August 10, 2023 |
| First Posted : | August 18, 2023 |
| Last Update Submitted that Met QC Criteria : | August 16, 2023 |
| Last Update Posted : | August 21, 2023 |